HeartSine recalls public access defibrillators

Candace Stuart | | Cardiovascular Business | Structural Heart Disease

HeartSine Technologies, the maker of Samaritan public access defibrillators, is voluntarily recalling its 300/300P devices because of a potential drain on batteries that could affect delivery of therapy in people experiencing sudden cardiac arrest.

The affected devices may intermittently turn off and on, depleting battery power. The company also announced that devices with early versions of software used to manage the battery may misinterpret voltage drops as a sign of a low battery and shut down the device. Both circumstances may prevent the device from delivering therapy.

The affected public access defibrillators were manufactured between August 2004 and December 2010 and have serial numbers of 0400000501 to 0700032917, 08A00035000 to 10A00070753 and 1C00200000 to 10C00210106. The company reported that it will send customers a new reserve PAD-PAK and hang tag with instructions as well as a software upgrade.

Customers are encouraged to arrange receipt of the free upgrade kit immediately. Physicians and patients can report adverse events and side effects related to affected devices to the FDA.

 

Candace Stuart, Contributor

Related Content

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement
Hydra TAVR valve gains key approval as global reach continues to grow
SAVR outperforms TAVR in patients with bicuspid aortic valves
Treating AFib patients with TAVR still linked to elevated risks
Heart surgeons detail world’s first robotic heart procedure of its kind
Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.